Encapsulating 2021

As we reflect on 2021 and welcome 2022, we feel so grateful for over 35 years of psychedelic research!

Highlights of the MAPS 2021 Timeline:

March 17

Alex Grey donates original artwork for our 35th anniversary

March 29

The first controlled trial of cannabis for the treatment of PTSD raised no safety concerns according to a published paper

April 8

MAPS debuts new logo in celebration of its 35th anniversary

May 3

MAPS’ Phase 3 trial of MDMA-assisted therapy for PTSD achieves successful results for patients with severe, chronic PTSD

May 4

MAPS is featured on the front page of The New York Times

May 10

MAPS is featured in Nature Medicine

May 12

MAPS wins appeal and authorization to study MDMA in healthy volunteer therapists

May 13- June 24

MAPS hosts Psychedelic Science Webinar Series

May 25

Synergetic Press and MAPS form copublishing partnership

June 4

MAPS Founder Rick Doblin is a guest on Joe Rogan’s Podcast

August 10

MAPS is awarded $12.9 million grant from Michigan to expand cannabis research for veterans with PTSD

Sept 14

MAPS announces $1.5 million from Wesana Health to evaluate a collaboration in TBI treatment

Nov 3

MAPS announces appointment of Carl L. Hart, Ph.D., to the Board of Directors

Nov 18

MAPS launches new website

Dec 11

Over 1,000 therapists trained in the MDMA Therapy Training Program with 231 scholarships provided.

Dec 16

Science Magazine names MAPS-sponsored therapy runner up for Breakthrough of the Year

Thank you to all our supporters for making 2021 an unforgettable year! 

Double Your Impact

With your support,
2022 will be another historic year for psychedelic science.